Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Japan doubles COVID-19 vaccine donation pledge to 60 mln doses

09/22/2021 | 11:52pm EDT

TOKYO, Sept 23 (Reuters) - Japan will double its COVID-19 vaccine donations to about 60 million doses intended for needy countries, Prime Minister Yoshihide Suga said at a virtual summit on Thursday.

The pledge adds to a previous agreement https://www.reuters.com/article/health-coronavirus-japan-covax-idCNL3N2NK0GL to provide 30 million doses and $1 billion to COVAX programme, overseen by the GAVI alliance and the World Health Organization.

"Japan has provided approximately 23 million doses of COVID vaccine to various countries and regions across the world, which is the third largest provision of vaccine in the world so far," Suga told the conference.

Much of Japan's vaccine donations thus far have been via bilateral agreements with Asian neighbours, outside of the COVAX program.

Japan is giving away most of its domestically produced supply of the vaccine developed by AstraZeneca Plc.

The nation has relied mainly on imported mRNA-type vaccines from Pfizer Inc and Moderna Inc for its inoculation push, which has fully vaccinated about 55% of its population https://www.kantei.go.jp/jp/headline/kansensho/vaccine.html, according to government data. (Reporting by Rocky Swift; Editing by Simon Cameron-Moore)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.33% 8768 Delayed Quote.19.72%
MODERNA, INC. -0.18% 333.01 Delayed Quote.218.76%
All news about ASTRAZENECA PLC
10/20ASTRAZENECA : Credit Suisse remains its Buy rating
MD
10/20ASTRAZENECA : Announces Winners and Recognizes Oncology Change Makers in Third Annual Canc..
BU
10/20ASTRAZENECA : Air Malta Transports Maltese Solidarity to Rwanda; 135,690 AstraZeneca vacci..
AQ
10/20KAROLINSKA INSTITUTET : Two COVID-19 Vaccine Doses Increase Airway Antibodies After Infect..
MT
10/20MODERNA : Germany may miss COVID-19 vaccine donation goal, blames manufacturers
RE
10/20ASTRAZENECA : Conference Chair Di Morris, AstraZeneca Invites You to Join SMi's 10th Annua..
AQ
10/20LONDON STOCK EXCHANGE : Nearly half of FTSE 100 companies have no net-zero target, Arabesq..
RE
10/20ASTRAZENECA : India delays COVID-19 vaccine supplies to WHO-backed COVAX, sources say
RE
10/19ASTRAZENECA : WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document
RE
10/19MODERNA : Germany may miss COVID-19 vaccine donation goal, blames manufacturers
RE
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 419 M - -
Net income 2021 4 868 M - -
Net Debt 2021 24 833 M - -
P/E ratio 2021 35,0x
Yield 2021 2,33%
Capitalization 188 B 188 B -
EV / Sales 2021 6,00x
EV / Sales 2022 4,85x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 121,17 $
Average target price 137,81 $
Spread / Average Target 13,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC19.72%186 853
JOHNSON & JOHNSON4.07%431 385
ROCHE HOLDING AG15.84%337 562
NOVO NORDISK A/S57.04%239 813
PFIZER, INC.14.34%235 986
ELI LILLY AND COMPANY44.35%219 674